Patent thicket
Patent thicket is a label used by generic companies for broad secondary patenting around a basic product, as recorded in the European Commission's 2009 Pharmaceutical Sector Inquiry1. The European Commission's 2009 inquiry notes that these terms are not defined in patent legislation1.
The FTC's 2003 report quoted Shapiro's description of overlapping intellectual property rights through which a company must navigate to commercialize technology2. A 2013 study commissioned by the UK IPO said the origins and especially the effects of patent thickets remained incompletely understood3.
The reports' terminology
The FTC's 2003 report attributes its description of a patent thicket to Shapiro in footnote 20 of the executive summary2.
The European Commission's 2009 inquiry says its industry terms are not intended to determine patent-law assessment, which instead uses statutory patentability criteria1.
Views recorded in the pharmaceutical inquiry
| Viewpoint | Attribution in the report |
|---|---|
| Generic companies | The European Commission's 2009 inquiry, paragraph 506, records generics calling broad secondary patenting around a basic product patent thickets1 |
| Originator companies and associations | The European Commission's 2009 inquiry, paragraph 502, records their objection that challenge outcomes do not substantially indicate the quality of patents in clusters because generic challengers select contentious, commercially interesting patents1 |
| Terminology caveat | The European Commission's 2009 inquiry, paragraph 20, says the label does not imply a negative assessment under patent law1 |
Research limits and the US consultation
The 2013 study commissioned by the UK IPO states that its findings and opinions are the researchers' and do not necessarily represent the IPO or government3.
The 2013 study commissioned by the UK IPO expressly notes that much remains to be learned about origins and effects3.
The USPTO's 2022 notice at 87 FR 67019 sought comments on USPTO-FDA collaboration initiatives, including discussion of the FDA's concerns about practices referred to as patent thickets, evergreening, and product hopping4.
Questions people ask
Check a product
FTO Search AI Agent
An AI agent that finds in-force patents that could read on your product, with a claim chart for each one.
Run FTO SearchIs patent thicket a statutory patent category?
No, the European Commission's 2009 inquiry places the term within industry terminology that is not defined in patent legislation1.
Does calling patents a thicket determine their validity?
No, the European Commission's 2009 terminology caveat says patentability depends on statutory criteria rather than these industry labels1.
Did the UK IPO study settle the effects of patent thickets?
No, the 2013 study commissioned by the UK IPO says much remains to be learned about their origins and especially their effects3.
How it connects
Go from the term to the task
Read how the method works, run it on your own product or idea, then try a free tool.
- 01 / How-toHow to run a freedom-to-operate analysisScope, search, claim review and the report counsel will ask for.Read
- 02 / AI agentFTO Search AI AgentAn AI agent that finds in-force patents that could read on your product, with a claim chart for each one.Run it